Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 87551-87600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05380713
......SMARTEST Trial......
PHASE2
Recruiting
30 participants
Started: May 3, 2022 · Completed: Oct 30, 2028
1 condition
2 sponsors
1 location
NCT07063940
Home-based EXercise and motivAtional Program Before and After Liver Transplantation
NA
Active, not recruiting
269 participants
Started: May 3, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
3 locations
NCT05087641
A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema
NA
Active, not recruiting
20 participants
Started: May 3, 2022 · Completed: Jan 31, 2027
2 conditions
1 sponsor
3 locations
NCT05187884
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
PHASE2
Active, not recruiting
15 participants
Started: May 3, 2022 · Completed: Nov 1, 2025
1 condition
1 sponsor
2 locations
NCT05296746
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2
Recruiting
1,100 participants
Started: May 3, 2022 · Completed: Dec 1, 2031
1 condition
3 sponsors
51 locations
NCT05323591
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
N/A
Active, not recruiting
155 participants
Started: May 3, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
17 locations
NCT05085704
Brain Metabolism Observed at 7 Tesla
N/A
Recruiting
20 participants
Started: May 3, 2022 · Completed: Sep 20, 2026
7 conditions
1 sponsor
1 location
NCT05298423
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
PHASE3
Active, not recruiting
611 participants
Started: May 3, 2022 · Completed: Aug 19, 2026
1 condition
1 sponsor
160 locations
NCT05221606
Nurse AMIE (Addressing Malignancies in Individuals Everyday)
NA
Active, not recruiting
344 participants
Started: May 3, 2022 · Completed: Mar 31, 2027
1 condition
5 sponsors
8 locations
NCT05269550
PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)
NA
Active, not recruiting
50 participants
Started: May 3, 2022 · Completed: Dec 15, 2028
1 condition
1 sponsor
2 locations
NCT04918186
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
PHASE2
Recruiting
60 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
7 locations
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
PHASE2
Recruiting
372 participants
Started: May 3, 2022 · Completed: Apr 14, 2029
1 condition
2 sponsors
183 locations
NCT05351424
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NA
Recruiting
194 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
2 locations
NCT05315414
Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations
NA
Active, not recruiting
138 participants
Started: May 3, 2022 · Completed: May 31, 2029
1 condition
1 sponsor
5 locations
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
N/A
Recruiting
7,000 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
20 conditions
1 sponsor
15 locations
NCT05356195
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
PHASE3
Recruiting
15 participants
Started: May 3, 2022 · Completed: May 31, 2026
5 conditions
2 sponsors
6 locations
NCT05338385
Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study
NA
Active, not recruiting
30 participants
Started: May 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04657861
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
EARLY_PHASE1
Recruiting
36 participants
Started: May 3, 2022 · Completed: Aug 20, 2027
2 conditions
2 sponsors
1 location
NCT06334627
Every Newborn-Reach Up Early Education Intervention for All Children- a Parent Group Intervention for School Readiness in Bangladesh, Nepal, and Tanzania
NA
Active, not recruiting
1,651 participants
Started: May 3, 2022 · Completed: Sep 15, 2024
2 conditions
5 sponsors
3 locations
NCT05369052
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
PHASE3
Recruiting
865 participants
Started: May 3, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
14 locations
NCT05533528
Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment
NA
Recruiting
25 participants
Started: May 3, 2022 · Completed: Feb 1, 2026
3 conditions
1 sponsor
1 location
NCT05296681
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
PHASE2
Recruiting
42 participants
Started: May 3, 2022 · Completed: Jul 1, 2025
5 conditions
1 sponsor
10 locations
NCT05197881
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
NA
Recruiting
125 participants
Started: May 3, 2022 · Completed: Sep 30, 2030
1 condition
1 sponsor
5 locations
NCT06366802
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
N/A
Active, not recruiting
1,000 participants
Started: May 3, 2022 · Completed: May 2, 2027
1 condition
1 sponsor
1 location
NCT05357638
Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body
NA
Recruiting
48 participants
Started: May 2, 2022 · Completed: Nov 2, 2025
2 conditions
2 sponsors
1 location
NCT05019963
Enhancing COVID Rehabilitation With Technology
NA
Active, not recruiting
106 participants
Started: May 2, 2022 · Completed: Sep 30, 2024
1 condition
3 sponsors
1 location
NCT05406856
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NA
Recruiting
30 participants
Started: May 2, 2022 · Completed: Dec 1, 2026
2 conditions
3 sponsors
2 locations
NCT05270044
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
PHASE3
Active, not recruiting
815 participants
Started: May 2, 2022 · Completed: May 2, 2035
1 condition
2 sponsors
155 locations
NCT05255302
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
PHASE2/PHASE3
Recruiting
1,360 participants
Started: May 2, 2022 · Completed: Jun 1, 2029
1 condition
1 sponsor
44 locations
NCT05258292
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
N/A
Recruiting
86 participants
Started: May 2, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT04506606
Cardiac Rehab Effects in HFpEF
NA
Recruiting
60 participants
Started: May 2, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05622006
Effect of Interrupting Sedentary Time With Different Frequencies of Physical Activity on Cardiometabolic Risk Factors
NA
Enrolling by invitation
25 participants
Started: May 2, 2022 · Completed: Oct 30, 2025
3 conditions
2 sponsors
1 location
NCT06361056
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
NA
Recruiting
80 participants
Started: May 2, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT05308108
Study of Postoperative Respiratory Complications in Children With Obstructive Sleep Apnea (PORC)
N/A
Recruiting
100 participants
Started: May 2, 2022 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT04878549
Transcriptomic Responses for the Identification of Pathogens
N/A
Recruiting
2,000 participants
Started: May 2, 2022 · Completed: Jun 30, 2025
5 conditions
3 sponsors
1 location
NCT05269225
Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project)
NA
Recruiting
100 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05079984
Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
NA
Active, not recruiting
35 participants
Started: May 2, 2022 · Completed: Oct 1, 2025
4 conditions
3 sponsors
1 location
NCT05199948
Weight, Energy, Lipids, and the Liver (WELL) Study
NA
Active, not recruiting
74 participants
Started: May 2, 2022 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT05147298
Community Walks: Clinical Trial
NA
Active, not recruiting
543 participants
Started: May 2, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT05615740
Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children
NA
Recruiting
150 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05262855
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
PHASE2
Active, not recruiting
60 participants
Started: May 2, 2022 · Completed: Oct 15, 2025
2 conditions
1 sponsor
4 locations
NCT04604951
Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury
NA
Recruiting
40 participants
Started: May 2, 2022 · Completed: Aug 31, 2024
5 conditions
4 sponsors
2 locations
NCT06588270
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia
NA
Recruiting
102 participants
Started: May 2, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05363189
Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)
N/A
Recruiting
380 participants
Started: May 2, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05039073
Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
PHASE2
Recruiting
46 participants
Started: May 2, 2022 · Completed: Nov 30, 2027
2 conditions
2 sponsors
2 locations
NCT05364801
Impact of Anxiety on the Decision-making Processes of Anesthesiologists
N/A
Recruiting
500 participants
Started: May 2, 2022 · Completed: Oct 31, 2024
3 conditions
1 sponsor
1 location
NCT05026060
Measurement of Brain Perfusion by a MR Perfusion Imaging Called eASL in Children's Cerebral Arteriopathies.
N/A
Recruiting
50 participants
Started: May 2, 2022 · Completed: May 31, 2028
1 condition
2 sponsors
1 location
NCT03738410
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
NA
Recruiting
80 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05303805
Topical Sevoflurane for Treatment of Chronic Leg Ulcers
PHASE4
Recruiting
50 participants
Started: May 2, 2022 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT05362890
The Role of the Device Operating Under the Continuous Positive Airway Pressure in the Recovery Process of Cochlea
NA
Recruiting
45 participants
Started: May 2, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
1749
1750
1751
1752
1753
1754
1755
More pages
2369
Next